Influence of metabolic syndrome and general obesity on the risk of ischemic stroke

Stroke

Volumn 37, Issue 4, 2006, Pages 1060-1064

  Chen, Hsin Jen ^a   Bai, Chyi Huey ^b   Yeh, Wen Ting ^a   Chiu, Hou Chang ^b   Pan, Wen Harn ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Epidemiology; Longitudinal studies; Metabolic syndrome X; Obesity; Stroke, ischemic

Indexed keywords

GLUCOSE;

ABDOMEN; ABDOMINAL OBESITY; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC VALUE; FEMALE; GENERAL OBESITY; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL RATE; TAIWAN; WAIST CIRCUMFERENCE; BRAIN ISCHEMIA; INCIDENCE; MIDDLE AGED; PREVALENCE;

ADULT; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TAIWAN;

EID: 33645832731     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000206458.58142.f3     Document Type: Article

References (20)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SCJ, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart. Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-2752.
2. Zimmet PZ, Alberti KG, Shaw JE. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust. 2005;183:175-176.
3. Yeh CJ, Pan WH, Bai CH, You MS, Wang WC, Wang LY, Lee TK. Curvilinear relations between age and hemostatic parameters in Chinese. Thromb Haemost. 1994;72:239-243.
4. Teh BH, Pan WH, Chen CJ. The reallocation of body fat toward the abdomen persists to very old age, while body mass index declines after middle age in Chinese. Int J Obes Relat Metab Disord. 1996;20:683-687.
5. Sugiuchi H, Uji Y, Okabe H, Me T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem. 1995;41:717-723.
6. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486-2497.
7. The Asia-Pacific Perspective: redefining obesity and its treatment. http:// www.diabetes.com.au/pdf/obesity_report.pdf 2000:20.
8. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev. 2002;3:141-146.
9. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation. 2003;107:391-397.
10. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc. 2002;288:2709-2716.
11. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250.
12. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack. A prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke. 2005;36:1366-1371.
13. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke. 2005;36:1372-1376.
14. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706-713.
15. Chan P, Lin TH, Pan WH, Lee YH. Thrombophilia associated with obesity in ethnic Chinese. Int J Obes Relat Metab Disord. 1995;19:756-759.
16. Mertens I, Van Gaal LF. Obesity, hemostasis and the fibrinolytic system. Obes Rev. 2002;3:85-101.
17. Engstrom G, Hedblad B, Stavenow L, Jonsson S, Lind P, Janzon L, Lindgarde F. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study. Arterioscler Thromb Vasc Biol. 2004;24:1498-1502.
18. Palmieri V, de Simone G, Amett DK, Bella JN, Kitzman DW, Oberman A, Hopkins PN, Province MA, Devereux RB. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (the Hypertension Genetic Epidemiology Network Study). Am J Cardiol. 2001;88:1163-1168.
19. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. J Am Med Assoc. 2003;290:486-494.
20. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-161.